{"text": ["ACR", "2018:", "Lilly", "Shares", "Updated", "Safety", "Analysis", "of", "OLUMIANT\u00ae", "(baricitinib)", "in", "Patients", "with", "Moderately-to-Severely", "Active", "Rheumatoid", "Arthritis"], "created_at": "2018-10-21 22:30:00"}
{"text": ["Lilly", "And", "Incyte", "Update", "Safety", "Analysis", "Of", "OLUMIANT"], "created_at": "2018-10-21 22:25:00"}
{"text": ["Lilly", "And", "Incyte", "Update", "Safety", "Analysis", "Of", "OLUMIANT"], "created_at": "2018-10-21 22:25:00"}
{"text": ["Better", "Buy:", "Biogen", "Inc.", "vs.", "Amgen", "Inc."], "created_at": "2018-10-21 14:07:40"}
{"text": ["Better", "Buy:", "Biogen", "Inc.", "vs.", "Amgen", "Inc."], "created_at": "2018-10-21 14:07:40"}
